Glycovir is an ester prodrug classified as an alpha-glucosidase inhibitor that has been investigated for potential antiviral activity against HIV and hepatitis viruses. By functioning as a prodrug, it… Read more
Glycovir is an ester prodrug classified as an alpha-glucosidase inhibitor that has been investigated for potential antiviral activity against HIV and hepatitis viruses. By functioning as a prodrug, it undergoes esterase-mediated hydrolysis to release the active iminosugar, which interferes with viral glycoprotein processing in host cells. This category includes high-quality reference standards of the Glycovir API, alongside a comprehensive range of pharmacopeial and non-pharmacopeial impurities. These compounds are essential for rigorous impurity profiling, method validation, and routine quality control processes in pharmaceutical laboratories. Additionally, stable isotope labelled compounds are available to serve as internal standards in mass spectrometry-based assays, ensuring accurate quantification and consistent monitoring of the drug and its related substances throughout the analytical lifecycle.